[Indications for and results of immunosupressive therapy in childhood chronic active hepatitis].
D000293:Adolescent; D000367:Age Factors; D000974:Antibodies, Antinuclear / Q000032:analysis; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006505:Hepatitis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D005719:gamma-Globulins / Q000032:analysis
D000974:Antibodies, Antinuclear; D006511:Hepatitis B Antigens; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D001379:Azathioprine; D011241:Prednisone
Indikationen und Ergebnisse immunsuppressiver Therapie bei chronisch aktiver Hepatitis im Kindesalter